2.88
-0.02(-0.69%)
Currency In USD
| Previous Close | 2.9 |
| Open | 2.95 |
| Day High | 2.95 |
| Day Low | 2.8 |
| 52-Week High | 4.86 |
| 52-Week Low | 2.51 |
| Volume | 70,316 |
| Average Volume | 442,677 |
| Market Cap | 8.77M |
| PE | -0.68 |
| EPS | -4.26 |
| Moving Average 50 Days | 3.12 |
| Moving Average 200 Days | 3.34 |
| Change | -0.02 |
If you invested $1000 in Kiora Pharmaceuticals, Inc. (KPRX) 10 years ago, it would be worth $0.11 as of June 30, 2025 at a share price of $2.88. Whereas If you bought $1000 worth of Kiora Pharmaceuticals, Inc. (KPRX) shares 5 years ago, it would be worth $1.66 as of June 30, 2025 at a share price of $2.88.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Kiora Pharmaceuticals and Senju Pharmaceutical Partner on KIO-301 for the Treatment of Retinal Diseases in Asia
Newsfile
Jun 03, 2025 11:00 AM GMT
Total potential deal value of $110 million plus royaltiesKiora to receive an immediate $1.25 million exclusive option feeIf the option is exercised, Kiora will receive an additional mid-single digit million up-front payment, development, regulatory,
Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy
Newsfile
May 05, 2025 11:00 AM GMT
Encinitas, California--(Newsfile Corp. - May 5, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the results from a preclinical study demonstrating KIO-104 significantly reduced scar formation in an estab
Kiora Pharmaceuticals to Present at The 24th Annual Needham Virtual Healthcare Conference
Newsfile
Apr 04, 2025 11:00 AM GMT
Ecinitas, California--(Newsfile Corp. - April 4, 2025) - Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company's online presentation at the 24th Annual Needham Virtual Healthcare Conference on Thursday, April 10th, 2025, at 2:15